Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Inpefa. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Sotagliflozin.
Level 2 evidence
Acebutolol
The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Acebutolol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sotagliflozin.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Sotagliflozin.
Level 2 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Sotagliflozin.
Level 1 evidence
Allopurinol
Sotagliflozin may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Level 2 evidence
Alogliptin
The risk or severity of hypoglycemia can be increased when Alogliptin is combined with Sotagliflozin.
Level 2 evidence
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Sotagliflozin.
Level 1 evidence
Ambrisentan
The serum concentration of Ambrisentan can be increased when it is combined with Sotagliflozin.
Level 2 evidence
Amcinonide
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Sotagliflozin.
Level 1 evidence
Aminosalicylic acid
Aminosalicylic acid may increase the hypoglycemic activities of Sotagliflozin.
Level 2 evidence
Amiodarone
The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Sotagliflozin.
Level 2 evidence
Enter your NPI to unlock 15 major interactions for Inpefa
Inpefa (Sotagliflozin) has 481 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Inpefa (Sotagliflozin) has 37 major, 411 moderate, and 33 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Inpefa. Always confirm against the full prescribing information.